Hainan Cancer Hospital
Clinical trials sponsored by Hainan Cancer Hospital, explained in plain language.
-
New immune combo targets hard-to-treat pancreatic cancer
Disease control Recruiting nowThis early-phase study tests a combination of two immune cell therapies (activated dendritic cells and CAR-T cells) in 10 people with advanced pancreatic cancer. The goal is to see if this approach is safe and can help the immune system better recognize and attack tumors. Partici…
Phase: EARLY_PHASE1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 08:29 UTC
-
Immune cell duo takes on tough tumors in early trial
Disease control Recruiting nowThis study tests a new treatment that combines two types of immune cells—dendritic cells and CAR-T cells—to fight advanced solid cancers like stomach, colon, and pancreatic cancer. The goal is to see if this combination is safe and can shrink tumors. About 10 adults will take par…
Phase: EARLY_PHASE1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 08:29 UTC